Preparation method of microcapsule with high stress resistance

High stress resistance microcapsules were prepared by spray drying combining whey protein, soy protein, sodium caseinate, collagen, gelatin and high molecular weight seaweed polysaccharides, which solved the stability and large-scale production of microcapsules in the prior art. The problem of this has achieved efficient core protection and stability improvement.

CN119056358AActive Publication Date: 2024-12-03THIRD INSTITUTE OF OCEANOGRAPHY STATE OCEANI C ADMINISTRATION
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411104033.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-12-03
Estimated Expiration
2044-08-13

AI Technical Summary

Technical Problem

The existing microcapsule preparation methods have problems such as high material cost, complex processing, low embedding efficiency, and unsuitable for large-scale production. They cannot show high stress resistance during processing, storage and digestion, especially for thermally sensitive core materials such as probiotics. The stability and bioavailability of bacteria and active drugs are difficult to guarantee.

Method used

Using whey protein, soy protein and sodium caseinate as wall material A, collagen and gelatin as wall material B, and seaweed polysaccharide as wall material C, high stress resistance microcapsules are prepared by spray drying. The specific steps include dissolving the wall. Materials A, B, and C are mixed evenly to form a suspension and spray-dried. The molecular weight of seaweed polysaccharides is preferably ≥1000KDa to improve the gastric and intestinal fluid resistance of the microcapsules.

Benefits of technology

It significantly improves the embedding rate of microcapsules and the survival rate of core materials, with an average diameter of less than 50μm, and significantly improves heat resistance and stability. It can not disintegrate and release in simulated gastric juice, maintain activity in simulated intestinal fluid, suitable for scale Chemical production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119056358A_ABST
    Figure CN119056358A_ABST
Patent Text Reader

Abstract

The invention provides a preparation method of microcapsules with high stress resistance, and belongs to the field of foods, pharmaceutical preparations or feeds. The microcapsule prepared by the preparation method has excellent technical effects of excellent high temperature resistance and digestive juice resistance, capability of protecting a core material from being inactivated in a spray drying process, high embedding rate, difficulty in disintegration in simulated gastric acid, good slow-release effect in simulated intestinal juice and the like; the stability of probiotics or medicines which are heat-sensitive and not resistant to digestive juice is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of food (including common food or health food), pharmaceutical preparation or feed, and in particular to a method for preparing microcapsules with high stress resistance. Background Art

[0002] Microencapsulation technology can provide a physical barrier for the core material, effectively mask the bad taste and odor of the core material, enhance its tolerance to adverse external environments, and improve stability. For heat-sensitive and unstable core materials such as probiotics and active drugs, microencapsulation technology is an important way to improve their stability and bioavailability. Probiotics in particular are extremely susceptible to adverse external environments during actual processing, storage, and digestion, resulting in a significant decrease in the number and activity of probiotics that eventually colonize the human intestine, or even complete inactivation, making it difficult to exert their probiotic effects. However, existing microcapsule preparation methods have problems such as high material cost, complex processing, low encapsulation efficiency, and unsuitability for large-scale production, and are unable to demonstrate high stress resistance during processing, storage, and digestion. For example:

[0003] Patent CN114287632A proposes a method for preparing sodium alginate-chitosan-inulin probiotic microcapsules by extrusion, which can improve the stability of probiotics in gastric juice, but its preparation efficiency is low and is not suitable for industrial production. In addition, the average particle size of the microcapsules reaches 4.5 mm, and the large particle size is not conducive to sensory evaluation during ingestion.

[0004] Spray drying is a commonly used microcapsule preparation technology with the advantages of low cost, simple operation, high preparation efficiency and continuous production. It is often used in industrial production. However, the high temperature during the spray drying process can cause great damage to the core material and further improvement is urgently needed.

[0005] In summary, there is currently no high-stress-resistant microcapsule that has good stability and can simply and effectively improve the tolerance of the core material during digestion and heat treatment and is suitable for large-scale preparation. Summary of the invention

[0006] In order to solve the above technical problems, the present invention provides the following technical solutions.

[0007] In a first aspect, the present invention provides a method for preparing high stress resistance microcapsules.

[0008] A method for preparing high stress resistance microcapsules comprises the following steps:

[0009] (1) dissolving a wall material A in water to obtain a wall material A solution, wherein the wall material A is at least one of whey protein, soy protein and sodium caseinate;

[0010] (2) dissolving wall material B in water to obtain a wall material B solution, wherein the wall material B is at least one of collagen and gelatin;

[0011] (3) dissolving wall material C in water to obtain a wall material C solution, wherein the wall material C is seaweed polysaccharide; and then uniformly mixing the wall material C solution with the wall material B solution to obtain a mixed solution 1;

[0012] (4) mixing the core material and the wall material A solution obtained in step (1) to obtain a mixed solution 2, and then adding the mixed solution 1 obtained in step (3) to the mixed solution 2, and mixing them thoroughly to obtain a suspension;

[0013] (5) spray drying the suspension obtained in step (4) to obtain the highly stress-resistant microcapsules.

[0014] In some embodiments, the molecular weight of the seaweed polysaccharide is ≥100 KDa. In some preferred embodiments, the molecular weight of the seaweed polysaccharide is ≥1000 KDa.

[0015] In some embodiments, the seaweed polysaccharide is at least one of Enteromorpha polysaccharide, Sargassum polysaccharide, Gracilaria polysaccharide, Ulva polysaccharide, and Laminaria polysaccharide. In some preferred embodiments, the seaweed polysaccharide is Enteromorpha polysaccharide. In some more preferred embodiments, the seaweed polysaccharide is Enteromorpha polysaccharide with a molecular weight of ≥1000KDa.

[0016] In some embodiments, the preparation method of the seaweed polysaccharide includes: using seaweed plants as raw materials, extracting by water extraction, and then separating, purifying, and drying to obtain the seaweed polysaccharide; the seaweed plants include at least one of Enteromorpha, Sargassum, Gracilaria, Ulva, and Laminaria.

[0017] In some embodiments, the preparation method comprises: extracting the seaweed plant in water at 80°C-100°C (e.g., 80°C, 85°C, 90°C, 95°C or 100°C) for 2h-6h, wherein 20g-500g (e.g., 20g, 30g, 40g, 50g, 60g, 70g, 80g, 90g, 100g, 150g, 200g, 250g, 300g, 350g, 400g, 450g or 500g) of the seaweed plant is added per liter of water; centrifuging, taking the supernatant, separating and purifying with a separation membrane, collecting the retentate, and drying to obtain the seaweed polysaccharide;

[0018] In some embodiments, the molecular weight cutoff of the separation membrane is 100 KDa. In some preferred embodiments, the molecular weight cutoff of the separation membrane is 1000 KDa.

[0019] In some embodiments, the content of wall material A in the suspension is 5 g / L to 20 g / L, calculated based on the total volume of the suspension. In some embodiments, the content of wall material A in the suspension is 5 g / L, 10 g / L, 15 g / L or 20 g / L, calculated based on the total volume of the suspension.

[0020] In some embodiments, the content of wall material B in the suspension is 10 g / L to 40 g / L, calculated based on the total volume of the suspension. In some embodiments, the content of wall material B in the suspension is 10 g / L, 15 g / L, 20 g / L, 25 g / L, 30 g / L, 35 g / L or 40 g / L, calculated based on the total volume of the suspension.

[0021] In some embodiments, the content of seaweed polysaccharide in the suspension is 1 g / L to 20 g / L, calculated based on the total volume of the suspension. In some embodiments, the content of seaweed polysaccharide in the suspension is 1 g / L, 2 g / L, 3 g / L, 4 g / L, 5 g / L, 6 g / L, 7 g / L, 8 g / L, 9 g / L, 10 g / L, 11 g / L, 12 g / L, 13 g / L, 14 g / L, 15 g / L, 16 g / L, 17 g / L, 18 g / L, 19 g / L or 20 g / L, calculated based on the total volume of the suspension.

[0022] In some embodiments, the core material is a probiotic, and the ratio of the number of live bacteria in the core material in step (4) to the total mass of the wall material A, the wall material B and the seaweed polysaccharide in the suspension is (10 6 ~10 11 ) CFU: 1g. In some embodiments, the core material is a probiotic, and the ratio of the number of live bacteria in the core material in step (4) to the total mass of the wall material A, the wall material B and the seaweed polysaccharide in the suspension is 10 6 CFU: 1g, 10 7 CFU: 1g, 10 8 CFU: 1g, 10 9 CFU: 1g, 10 10 CFU: 1g or 10 11 CFU:1g.

[0023] In some embodiments, the core material is a drug, and the mass ratio of the core material in step (4) to the total mass of the wall material A, the wall material B and the seaweed polysaccharide in the suspension is (0.1-1.0):1.0. In some embodiments, the core material is a drug, and the mass ratio of the core material in step (4) to the total mass of the wall material A, the wall material B and the seaweed polysaccharide in the suspension is 0.1:1.0, 0.2:1.0, 0.3:1.0, 0.4:1.0, 0.5:1.0, 0.6:1.0, 0.7:1.0, 0.8:1.0, 0.9:1.0 or 1.0:1.0.

[0024] In some embodiments, the step (2) of dissolving the wall material B in water is performed at 50°C to 80°C.

[0025] In some embodiments, the step (2) of dissolving the wall material B in water is performed at 50°C, 55°C, 60°C, 65°C, 70°C, 75°C or 80°C.

[0026] In some embodiments, the step (3) of dissolving seaweed polysaccharide in water is carried out at 50° C. to 80° C. In some embodiments, the step (3) of dissolving seaweed polysaccharide in water is carried out at 50° C., 55° C., 60° C., 65° C., 70° C., 75° C. or 80° C.

[0027] In some embodiments, the spray drying parameters in step (5) are that the inlet temperature is 100°C to 180°C, the outlet temperature is 60°C to 100°C, and the feed flow rate is 5mL / min to 20mL / min. In some embodiments, the spray drying parameters in step (5) are that the inlet temperature is 100°C, 110°C, 120°C, 130°C, 140°C, 150°C, 160°C, 170°C or 180°C, the outlet temperature is 60°C, 70°C, 80°C, 90°C or 100°C, and the feed flow rate is 5mL / min, 6mL / min, 7mL / min, 8mL / min, 9mL / min, 10mL / min, 11mL / min, 12mL / min, 13mL / min, 14mL / min, 15mL / min, 16mL / min, 17mL / min, 18mL / min, 19mL / min or 20mL / min.

[0028] In some embodiments, the probiotics include at least one of Lactobacillus plantarum, Bifidobacterium, Lactobacillus casei, and Bacillus subtilis.

[0029] In some embodiments, the drug includes at least one of ibuprofen, norfloxacin, avermectin, and enrofloxacin.

[0030] In a second aspect, the present invention provides a high stress resistance microcapsule prepared according to the preparation method described in the first aspect.

[0031] A highly stress-resistant microcapsule prepared according to the preparation method of the first aspect.

[0032] In a third aspect, the present invention provides a pharmaceutical preparation.

[0033] A pharmaceutical preparation comprises the high stress resistance microcapsules prepared according to the preparation method of the first aspect or the high stress resistance microcapsules of the second aspect.

[0034] In a fourth aspect, the present invention provides a food.

[0035] A food comprises the high stress resistance microcapsules prepared by the preparation method of the first aspect or the high stress resistance microcapsules of the second aspect, wherein the core material of the high stress resistance microcapsules is probiotics.

[0036] In some embodiments, the food is ordinary food or health food.

[0037] In a fifth aspect, the present invention provides a feed.

[0038] A feed comprises the high stress resistance microcapsules prepared by the preparation method of the first aspect or the high stress resistance microcapsules of the second aspect, wherein the core material of the high stress resistance microcapsules is probiotics.

[0039] Beneficial Effects

[0040] Compared with the prior art, the technical solution provided by the present invention has at least one of the following beneficial technical effects:

[0041] (1) The preparation method provided by the present invention is simple in process. The seaweed polysaccharide-based wall material provided by the present invention can reduce the effects of high temperature and dehydration on the activity of the core material during spray drying. The average diameter of the obtained high stress resistance microcapsules is less than 50 μm, and the embedding rate is ≥90%. The obtained microcapsules have a high embedding rate, a high survival rate of the probiotic core material after spray drying, and a low loss rate of the high temperature unstable drug core material after spray drying.

[0042] (2) The high stress-resistant microcapsules prepared by the preparation method provided by the present invention can improve the stability of the core material during digestion. The high stress-resistant microcapsules do not disintegrate in simulated gastric fluid and have a good sustained-release effect in simulated intestinal fluid.

[0043] (3) Compared with not adding any one of the wall materials A, B and C described in the present invention, the microcapsules obtained by adding the wall materials A, B and C provided by the present invention at the same time have an unexpected technical effect of being resistant to gastric juice, which is beneficial to avoid the probiotics or drugs in the microcapsules from being destroyed in gastric juice or intestinal juice.

[0044] (4) Compared with the same period, the microcapsules obtained by adding the wall materials A, B and C provided by the present invention at the same time without adding any of the wall materials A, B and C described in the present invention have an unexpected technical effect of resistance to intestinal fluid (containing bile salts).

[0045] (5) Compared with seaweed polysaccharides of other molecular weights, the microcapsules obtained using the seaweed polysaccharides with a molecular weight (preferably ≥1000 KDa) provided by the present invention have unexpected technical effects of resistance to gastric juice and intestinal juice (including bile salts), which is beneficial to prevent the probiotics or drugs in the microcapsules from being destroyed in gastric juice or intestinal juice.

[0046] (6) Compared with other seaweed polysaccharides, the microcapsules obtained using the seaweed polysaccharide type provided by the present invention have unexpected technical effects of resistance to gastric juice and intestinal juice (containing bile salts), which is beneficial to prevent the probiotics or drugs in the microcapsules from being destroyed in gastric juice or intestinal juice.

[0047] (7) The high stress resistance microcapsules prepared by the preparation method provided by the present invention can significantly improve the heat resistance of the core material (for example: with probiotics as the core material, heat treatment at 60°C for 30 minutes, the survival rate of probiotics is ≥90%; heat treatment at 90°C for 10 minutes, the survival rate of probiotics is ≥6%), which has unexpected technical effects and is beneficial to the processing stability and storage stability of the microcapsules.

[0048] (8) Compared with seaweed polysaccharides of other molecular weights, the microcapsules obtained using the seaweed polysaccharides with a molecular weight (preferably ≥1000 KDa) provided by the present invention have an unexpected technical effect of high temperature resistance, which is beneficial to the processing stability and storage stability of the microcapsules.

[0049] (9) Compared with other seaweed polysaccharides, the microcapsules obtained by using the seaweed polysaccharide type provided by the present invention have unexpected high temperature resistance technical effects, which is beneficial to the processing stability and storage stability of the microcapsules.

[0050] Terminology

[0051] In the above text of the present invention, regardless of whether the words "about" or "approximately" are used, all the numbers disclosed herein are approximate values. Based on the disclosed numbers, the value of each number may vary by less than ±10% or reasonable differences considered by those skilled in the art, such as ±1%, ±2%, ±3%, ±4% or ±5%.

[0052] The terms "optional", "optional" or "optionally" mean that the subsequently described event or circumstance may but need not occur.

[0053] The term "and / or" should be understood to mean any one of the optional items or a combination of any two or more of the optional items.

[0054] The term "wt%" means percent by mass.

[0055] The term "KDa" means kilodaltons.

[0056] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction. BRIEF DESCRIPTION OF THE DRAWINGS

[0057] Figure 1 It is a curve diagram of the release of Example 3, Example 4, Example 5 and Comparative Example 2 in Experimental Example 3 in simulated gastric fluid and simulated intestinal fluid environments respectively. DETAILED DESCRIPTION

[0058] In order to enable those skilled in the art to better understand the technical solution of the present invention, some non-limiting embodiments are further disclosed below to further illustrate the present invention in detail.

[0059] The reagents or consumables used in the present invention can be purchased from the market or prepared by the method described in the present invention.

[0060] The plant lactobacillus sources used in the following embodiments or comparative examples are:

[0061] Lactobacillus plantarum: Lactiplantibacillus plantarum, strain number DSM 20174.

[0062] Example 1: Preparation of seaweed polysaccharides

[0063] The seaweed plant is extracted in 90°C water for 3 hours, wherein 50g of the seaweed plant is added per liter of water; centrifugation is performed, the supernatant is taken, and separation and purification is performed using a separation membrane with a molecular weight cutoff of 100KDa, the retentate is collected, and drying is performed to obtain the seaweed polysaccharide, wherein the molecular weight of the seaweed polysaccharide is ≥100KDa. The seaweed plant is selected from Enteromorpha, Sargassum, Gracilaria, Ulva or Laminaria, respectively, to obtain Enteromorpha polysaccharide, Sargassum polysaccharide, Gracilaria polysaccharide, Ulva polysaccharide or Laminaria polysaccharide.

[0064] Example 2: Preparation of seaweed polysaccharides

[0065] The seaweed plant is extracted in 90°C water for 3 hours, wherein 50g of the seaweed plant is added per liter of water; centrifugation is performed, the supernatant is taken, and separation and purification is performed using a separation membrane with a molecular weight cutoff of 1000KDa, the retentate is collected, and drying is performed to obtain the seaweed polysaccharide, wherein the molecular weight of the seaweed polysaccharide is ≥1000KDa. The seaweed plant is selected from Enteromorpha, Sargassum, Gracilaria, Ulva, Laminaria or Coralline, respectively, to obtain Enteromorpha polysaccharide, Sargassum polysaccharide, Gracilaria polysaccharide, Ulva polysaccharide, Laminaria polysaccharide or Coralline polysaccharide.

[0066] Example 3-Example 6: Preparation of highly stress-resistant probiotic microcapsules

[0067] Recipe: See Table 1.

[0068] Table 1: High stress resistance probiotic microcapsule formulation, average microcapsule diameter, spray drying survival rate and encapsulation rate

[0069]

[0070]

[0071] Preparation method:

[0072] 1. Preparation of core material

[0073] The plant lactobacillus strain was inoculated into MRS medium, kept at 37°C, and cultured at 120 rpm for 14 h for activation. The activated plant lactobacillus culture solution was cultured again according to the above operation to obtain a twice activated plant lactobacillus strain culture solution. 1 L of the twice activated plant lactobacillus culture solution was taken, and the viable bacteria concentration was about 10 8 CFU / mL, and after centrifugation at 8000 rpm for 10 min, the wet bacteria were collected to obtain the core material.

[0074] 2. Preparation method of highly stress-resistant probiotic microcapsules

[0075] (1) dissolving wall material A in water to obtain a wall material A solution;

[0076] (2) dissolving wall material B in 70° C. water to obtain a wall material B solution;

[0077] (3) dissolving wall material C in 70° C. water to obtain a wall material C solution; and then mixing the wall material C solution with the wall material B solution to obtain a mixed solution 1;

[0078] (4) The core material is mixed with the wall material A solution obtained in step (1) to obtain a mixed solution 2, and the mixed solution 1 obtained in step (3) is added to the mixed solution 2, and the mixture is evenly mixed to obtain a suspension, wherein the content of the wall material A in the suspension is 10 g / L, the content of the wall material B is 20 g / L, and the content of the wall material C is 5 g / L; 10 8 CFU core material;

[0079] (5) spray drying the suspension obtained in step (4) to obtain the highly stress-resistant microcapsules; the spray drying parameters are: inlet air temperature of 180° C., outlet air temperature of 80° C., and feed flow rate of 10 mL / min.

[0080] The average diameter of microcapsules, spray drying survival rate and embedding efficiency are shown in Table 1.

[0081] Comparative Example 1: Preparation of probiotic powder

[0082] The plant lactobacillus strain was inoculated into MRS medium, kept at 37°C, and cultured at 120 rpm for 14 h for activation. The activated plant lactobacillus culture solution was cultured again according to the above operation to obtain a twice activated plant lactobacillus strain culture solution. 1 L of the twice activated plant lactobacillus culture solution was taken, and the viable bacteria concentration was about 10 8 CFU / mL, and after centrifugation at 8000 rpm for 10 min, the bacterial precipitate was collected and evenly dispersed in 1 L of sterile water to obtain a bacterial suspension.

[0083] The bacterial suspension was spray dried while being stirred, with an inlet air temperature of 180°C, an outlet air temperature of 80°C, and a feed flow rate of 10 mL / min. White Lactobacillus plantarum powder was collected, and the spray drying survival rate of Lactobacillus plantarum was only 0.01%.

[0084] Comparative Example 2-Comparative Example 4: Investigation of wall materials

[0085] The wall material was investigated based on the formula of Example 3. The specific formula is shown in Table 2.

[0086] Table 2: Probiotic microcapsule formulation, average microcapsule diameter, spray drying survival rate and encapsulation rate

[0087]

[0088]

[0089] Preparation method:

[0090] 1. Preparation of core material

[0091] The preparation of the core material is the same as in Example 3 to Example 6.

[0092] 2. Preparation method of highly stress-resistant probiotic microcapsules

[0093] Refer to the preparation method of highly stress-resistant probiotic microcapsules in Example 3, wherein the components not added in each comparative example are replaced by corresponding weight portions of water, and the remaining operations are the same as in Example 3.

[0094] Comparative Example 7-Comparative Example 9: Investigation of Wall Materials C with Different Molecular Weights

[0095] Based on the formula of Example 3, wall materials C with different molecular weights were investigated. The specific formula is shown in Table 3.

[0096] Table 3: Investigation of wall materials C with different molecular weights

[0097]

[0098]

[0099] 1. Preparation method of seaweed polysaccharide

[0100] (1) Preparation method of Enteromorpha polysaccharide (molecular weight 50KDa~100KDa): extract Enteromorpha in 90℃ water for 3h, wherein 50g of Enteromorpha is added to every liter of water; centrifuge, take the supernatant, separate and purify it with a separation membrane with a molecular weight cutoff of 100KDa, collect the permeate, separate and purify it with a separation membrane with a molecular weight cutoff of 50KDa, collect the retentate, and dry to obtain Enteromorpha polysaccharide (molecular weight 50KDa~100KDa).

[0101] (2) Preparation method of Enteromorpha polysaccharide (molecular weight 10KDa~50KDa): extract Enteromorpha in 90℃ water for 3h, wherein 50g of Enteromorpha is added to every liter of water; centrifuge, take the supernatant, separate and purify it with a separation membrane with a molecular weight cutoff of 50KDa, collect the permeate, separate and purify it with a separation membrane with a molecular weight cutoff of 10KDa, collect the retentate, and dry to obtain Enteromorpha polysaccharide (molecular weight 10KDa~50KDa).

[0102] (3) Preparation method of Enteromorpha polysaccharide (molecular weight <10KDa): extract the Enteromorpha in 90°C water for 3 hours, wherein 50g of the Enteromorpha is added to every liter of water; centrifuge, take the supernatant, separate and purify it using a separation membrane with a molecular weight cutoff of 10KDa, collect the permeate, and dry it to obtain the Enteromorpha polysaccharide (molecular weight <10KDa).

[0103] 2. Microcapsule preparation method:

[0104] 1. Preparation of core material

[0105] The preparation of the core material is the same as in Example 3 to Example 6.

[0106] 2. Preparation method of highly stress-resistant probiotic microcapsules

[0107] The preparation method of highly stress-resistant probiotic microcapsules in Reference Example 3 is different in the selection of wall material C, and the rest of the operations are the same as in Example 3.

[0108] Comparative Example 10-Comparative Example 12: Investigation of different seaweed polysaccharides

[0109] Different seaweed polysaccharides were investigated based on the formula of Example 3. The specific formula is shown in Table 4.

[0110] Table 4: Investigation of different seaweed polysaccharides

[0111]

[0112] Preparation method:

[0113] 1. Preparation of core material

[0114] The preparation of the core material is the same as in Example 3 to Example 6.

[0115] 2. Preparation method of highly stress-resistant probiotic microcapsules

[0116] The preparation method of highly stress-resistant probiotic microcapsules in Reference Example 3 is different in the selection of wall material C, and the rest of the operations are the same as in Example 3.

[0117] Test Example 1: Determination of survival rate in simulated gastric fluid and simulated intestinal fluid

[0118] 1. Solution preparation

[0119] (1) Preparation of simulated gastric fluid (pH 1.8): Measure 80 mL of ultrapure water, add 1 g of pepsin and disperse evenly, adjust the pH to 1.8 with 10% hydrochloric acid, transfer to a 100 mL volumetric flask, and filter with a 0.22 μm sterile filter membrane for later use.

[0120] (2) Preparation of simulated intestinal fluid (pH 6.8): Prepare 0.2 mol / L pH 6.8 phosphate buffer, add trypsin at a final concentration of 1 mg / mL and ox bile salt at a final concentration of 3 mg / mL, and after complete dissolution, filter with a 0.22 μm sterile filter membrane for later use.

[0121] 2. Operation

[0122] (1) The probiotic microcapsules or probiotic powder prepared in the above examples or comparative examples were added to simulated gastric fluid (pH 1.8), incubated at a constant temperature of 37°C and 100 rpm for 2 h, and centrifuged at 8000 rpm for 5 min to collect the probiotic microcapsules or probiotic powder, and diluted with sterile water after breaking the wall. The total number of colonies was determined by the plate count method of GB4789.2-2016. The results are shown in Table 1.

[0123] (2) The probiotic microcapsules or probiotic powder prepared in the above examples or comparative examples were added to the simulated intestinal fluid (pH 6.8), incubated at a constant temperature of 37°C and 100 rpm for 2 h, and centrifuged at 8000 rpm for 5 min to collect the probiotic microcapsules or probiotic powder, and diluted with sterile water after breaking the wall. The total number of colonies was determined by the plate count method of GB4789.2-2016. The results are shown in Table 5.

[0124] Survival rate in simulated gastric fluid = number of colonies after treatment with simulated gastric fluid / total number of initial colonies × 100%

[0125] Survival rate in simulated intestinal fluid = number of colonies after treatment with simulated intestinal fluid / total number of initial colonies × 100%

[0126] Table 5: Survival rates of different probiotic microcapsules or probiotic powders in simulated gastric fluid and simulated intestinal fluid

[0127]

[0128]

[0129] in conclusion:

[0130] (1) Comparative Example 1 is a naked probiotic bacteria, which has poor tolerance in simulated gastric juice. After 2 hours of cultivation in simulated gastric juice, the survival rate of live bacteria is 0%. The microcapsules of Comparative Example 2 do not contain seaweed polysaccharides in the wall material, and the protective effect on probiotics is relatively poor. After 2 hours of cultivation in simulated gastric juice, the survival rate of live bacteria is 12%. Although the microcapsules of Comparative Examples 3 and 4 have the addition of Enteromorpha polysaccharides, they do not contain sodium caseinate or gelatin. After 2 hours of cultivation in simulated gastric juice, the survival rate of live bacteria is 0%. Comparative Examples 5 and 6 are single sodium caseinate or gelatin microcapsules. After 2 hours of cultivation in simulated gastric juice, the survival rate of live bacteria is 0.2% or 1.3%, respectively; compared with not adding any of the wall materials A, B and C described in the present invention, the microcapsules obtained by adding the wall materials A, B and C provided by the present invention (Examples 3-Example 6) have unexpected technical effects of resistance to simulated gastric juice.

[0131] (2) Similarly, compared with not adding any one of the wall materials A, B and C described in the present invention, the microcapsules obtained by adding the wall materials A, B and C provided by the present invention at the same time (Example 3-Example 6) have an unexpected technical effect of resistance to simulated intestinal fluid (containing bile salts).

[0132] (3) Although the microcapsules of Comparative Examples 7 to 9 have Enteromorpha polysaccharide added, the molecular weight of Enteromorpha polysaccharide is less than 10 KDa. The smaller the molecular weight, the worse the protective effect on probiotics in simulated gastric juice or simulated intestinal juice. Therefore, it is shown that compared with seaweed polysaccharides of other molecular weights, the microcapsules obtained by using seaweed polysaccharides with a molecular weight (preferably ≥1000 KDa) provided by the present invention have unexpected technical effects of resistance to gastric juice and intestinal juice (containing bile salt).

[0133] (4) The microcapsules of Comparative Examples 10 to 12 respectively contain coralline algae polysaccharides, sodium alginate and carrageenan, but the survival rate of probiotics in simulated gastrointestinal fluid is significantly lower than that of Examples 3 to 6, indicating that compared with other seaweed polysaccharides, the microcapsules obtained using the seaweed polysaccharide type provided by the present invention have unexpected technical effects of resistance to gastric juice and intestinal fluid (containing bile salts).

[0134] In summary, from the above experimental results (Table 5), it can be seen that after the probiotics are encapsulated in seaweed polysaccharide / sodium caseinate / gelatin microcapsules (Examples 3 to 6), their tolerance to simulated gastrointestinal fluid is significantly improved, thereby enhancing the stability of the probiotics in the digestive fluid.

[0135] Test Example 2: Determination of survival rate during heat treatment

[0136] The probiotic microcapsules or probiotic powders prepared in the above examples or comparative examples were heat treated at 60°C for 30 min and 90°C for 10 min, respectively, and then gradiently diluted with sterile water, and the total number of colonies was determined by the plate count method of GB4789.2-2016. The results are shown in Table 6.

[0137] Heat treatment survival rate = number of colonies after heat treatment / total number of initial colonies × 100%

[0138] Table 6: Survival rates of different probiotic microcapsules or probiotic powders during heat treatment

[0139] sample Survival rate after heat treatment at 60℃ for 30min Survival rate after 10 min heat treatment at 90℃ Example 3 94% 29% Example 4 90% 30% Example 5 91% 6% Example 6 90% 13% Comparative Example 1 0 0 Comparative Example 2 71% 0.29% Comparative Example 7 36% 0.5% Comparative Example 8 15% 0 Comparative Example 9 3% 0 Comparative Example 10 93% 0.05% Comparative Example 11 11% 0 Comparative Example 12 5% 0

[0140] in conclusion:

[0141] (1) Comparative Example 1 is a naked probiotic bacteria, which has poor tolerance in high temperature environment, and the survival rate of live bacteria is 0%. Comparative Example 2 has no seaweed polysaccharide in the microcapsule wall material, and the protective effect on the probiotics in high temperature environment is limited. However, the microcapsules provided by the present invention (Examples 3-6) have unexpected high temperature resistance technical effects.

[0142] (2) Although the microcapsules of Comparative Examples 7 to 9 contain Enteromorpha polysaccharide, the molecular weight of Enteromorpha polysaccharide is less than 10 KDa. The smaller the molecular weight, the worse the protective effect on probiotics under high temperature environment. This indicates that compared with seaweed polysaccharides of other molecular weights, the microcapsules obtained using seaweed polysaccharides with a molecular weight (preferably ≥1000 KDa) provided by the present invention have an unexpected technical effect of high temperature resistance.

[0143] (3) In the microcapsules of Comparative Examples 10 to 12, coralline algae polysaccharide, sodium alginate and carrageenan are used to replace the seaweed polysaccharide in Example 3, respectively. However, the microcapsules obtained after the replacement have limited protective effects on probiotics in a high temperature environment. This indicates that compared with other seaweed polysaccharides, the microcapsules obtained using the seaweed polysaccharide type provided by the present invention have unexpected high temperature resistance technical effects.

[0144] In summary, from the above experimental results (Table 5), it can be seen that after the probiotics are encapsulated in seaweed polysaccharide / sodium caseinate / gelatin microcapsules (Examples 3 to 6), they have good heat resistance, which greatly improves the tolerance of the probiotics in high temperature environments.

[0145] Test Example 3: Release in gastrointestinal fluid environment

[0146] The probiotic microcapsules prepared in the above examples or comparative examples were added to simulated gastric fluid, and the mixture was shaken at 37°C and 100 rpm. OD values ​​were measured after 0, 30, 60, 90 and 120 min. 600 After the simulated gastric fluid treatment, the simulated gastric fluid was centrifuged and discarded, and then added to the simulated intestinal fluid, and the mixture was kept at a constant temperature of 37°C and 100 rpm for constant temperature shaking. The OD was measured at 60 min, 120 min, 180 min, and 240 min after adding the simulated intestinal fluid. 600 , the results are shown in Figure 1 .

[0147] Conclusion: The high stress resistance microcapsules of the embodiment are stable in simulated gastric fluid for 2 hours, not easy to disintegrate and leak probiotics, and can gradually disintegrate and release probiotics in simulated intestinal fluid, with significant sustained release / controlled release effect. Comparative Example 2 is relatively stable in simulated gastric fluid for 2 hours, not easy to leak probiotics, and can disintegrate and release probiotics within 1 hour in simulated intestinal fluid, but has no obvious sustained release effect.

[0148] Example 7: Preparation of Enrofloxacin Microcapsules

[0149] Recipe: See Table 7.

[0150] Table 7: Formula of enrofloxacin microcapsules, average diameter of microcapsules, enrofloxacin content after spray drying and embedding rate

[0151]

[0152]

[0153] Preparation method:

[0154] (1) dissolving wall material A in water to obtain a wall material A solution;

[0155] (2) dissolving wall material B in 70° C. water to obtain a wall material B solution;

[0156] (3) dissolving wall material C in 70° C. water to obtain a wall material C solution; and then mixing the wall material C solution with the wall material B solution to obtain a mixed solution 1;

[0157] (4) mixing the core material with the wall material A solution obtained in step (1) to obtain a mixed solution 2, and then adding the mixed solution 1 obtained in step (3) to the mixed solution 2, mixing evenly to obtain a suspension; the content of the wall material A in the suspension is 10 g / L, the content of the wall material B in the suspension is 20 g / L, and the content of the wall material C in the wall material C is 5 g / L; 0.5 g of the core material is added for every 1 g of the total wall material (i.e., wall material A+wall material B+wall material C);

[0158] (5) spray drying the suspension obtained in step (4) to obtain the highly stress-resistant microcapsules; the spray drying parameters are: inlet air temperature of 180° C., outlet air temperature of 80° C., and feed flow rate of 10 mL / min.

[0159] The average diameter of microcapsules, spray drying survival rate and embedding rate are shown in Table 7.

[0160] The method of the present invention has been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein within the content, spirit and scope of the present invention to implement and apply the technology of the present invention. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters. It is particularly important to point out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention.

Claims

1. A method for preparing high stress resistance microcapsules, characterized in that: The following steps are involved: (1) dissolving a wall material A in water to obtain a wall material A solution, wherein the wall material A is at least one of whey protein, soy protein and sodium caseinate; (2) dissolving wall material B in water to obtain a wall material B solution, wherein the wall material B is at least one of collagen and gelatin; (3) dissolving wall material C in water to obtain a wall material C solution, wherein the wall material C is seaweed polysaccharide; and then uniformly mixing the wall material C solution with the wall material B solution to obtain a mixed solution 1; (4) mixing the core material and the wall material A solution obtained in step (1) to obtain a mixed solution 2, and then adding the mixed solution 1 obtained in step (3) to the mixed solution 2, and mixing them thoroughly to obtain a suspension; (5) spray drying the suspension obtained in step (4) to obtain the highly stress-resistant microcapsules.

2. The preparation method according to claim 1, wherein the molecular weight of the seaweed polysaccharide is ≥100KDa, preferably ≥1000KDa; Optionally, the seaweed polysaccharide is at least one of Enteromorpha polysaccharide, Sargassum fusiformis polysaccharide, Gracilaria lemaneiformis polysaccharide, Ulva polysaccharide, and Laminaria japonica polysaccharide; Preferably, the seaweed polysaccharide is Enteromorpha polysaccharide; More preferably, the seaweed polysaccharide is Enteromorpha polysaccharide with a molecular weight of ≥1000 KDa.

3. The preparation method according to any one of claims 1 to 2, wherein the preparation method of seaweed polysaccharide comprises: The seaweed polysaccharide is obtained by using seaweed plants as raw materials through water extraction, separation, purification and drying; the seaweed plants include at least one of Enteromorpha, Sargassum, Gracilaria, Ulva and Laminaria.

4. The preparation method according to claim 3, comprising: Extracting seaweed plants in water at 80°C-100°C for 2h-6h, wherein 20g-500g of the seaweed plants are added per liter of water; centrifuging, taking the supernatant, separating and purifying with a separation membrane, collecting the retentate, and drying to obtain the seaweed polysaccharide; Optionally, the molecular weight cutoff of the separation membrane is 100 KDa; preferably, the molecular weight cutoff of the separation membrane is 1000 KDa.

5. The preparation method according to any one of claims 1 to 4, wherein the content of the wall material A in the suspension is 5 g / L to 20 g / L, calculated based on the total volume of the suspension; and / or The content of the wall material B in the suspension is 10 g / L to 40 g / L, calculated based on the total volume of the suspension; and / or The content of seaweed polysaccharide in the suspension is 1 g / L to 20 g / L, calculated based on the total volume of the suspension; and / or The core material is a probiotic, and the ratio of the number of live bacteria in the core material in step (4) to the total mass of the wall material A, the wall material B and the seaweed polysaccharide in the suspension is (10 6 ~10 11 ) CFU: 1g; or the core material is a drug, and the mass ratio of the mass of the core material in the step (4) to the total mass of the wall material A, the wall material B and the seaweed polysaccharide in the suspension is (0.1-1.0):1.

0.

6. The preparation method according to any one of claims 1 to 5, wherein the step (2) of dissolving the wall material B in water is performed at 50°C to 80°C; and / or In step (3), the seaweed polysaccharide is dissolved in water at 50° C. to 80° C.; and / or The parameters of the spray drying in step (5) are as follows: an inlet air temperature of 100°C to 180°C, an outlet air temperature of 60°C to 100°C, and a feed flow rate of 5 mL / min to 20 mL / min.

7. The preparation method according to claim 5, wherein the probiotics include at least one of Lactobacillus plantarum, Bifidobacterium, Lactobacillus casei, and Bacillus subtilis; and / or The drug includes at least one of ibuprofen, norfloxacin, avermectin and enrofloxacin.

8. A highly stress-resistant microcapsule prepared according to the preparation method according to any one of claims 1 to 7.

9. A pharmaceutical preparation comprising the high stress resistance microcapsules prepared by the preparation method according to any one of claims 1 to 7 or the high stress resistance microcapsules according to claim 8.

10. A food or feed comprising the high stress resistance microcapsules prepared by the preparation method according to any one of claims 1 to 7 or the high stress resistance microcapsules according to claim 8, wherein the core material of the high stress resistance microcapsules is probiotics.

Citation Information

Patent Citations

  • Edible microcapsule for indicating probiotics activity and preparation method and application thereof

    CN103169140A

  • Preparation method of pesticide microcapsule containing organic silicon

    CN104012528A

  • Abamectin microcapsule powder prepared from lignin-based wall material and method for preparing abamectin microcapsule powder by use of lignin-based wall material

    CN105010362A

  • Preparation method of composition containing probiotics and unsaturated fatty acids and application of composition

    CN106387967A

  • AU1589388A